Showing results (1-10 of 296) with videos related to
Sort By:
Pageof 30
Neuroscience|January 1, 1991
Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor bindingR C Pierce, J K Rowlett, M T Bardo, et al.Brain Research|August 7, 1995
Ascorbate potentiates amphetamine-induced conditioned place preference and forebrain dopamine release in ratsR C Pierce, J K Rowlett, G V Rebec, et al.Neuroscience|February 1, 1997
Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during noveltyG V Rebec, C P Grabner, M Johnson, et al.European Journal of Pharmacology|December 4, 1990
Stimulation of both D1 and D2 dopamine receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving ratsR C Pierce, G V RebecThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1993
Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanismsR C Pierce, G V RebecProgress in Neurobiology|August 1, 1994
A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmissionG V Rebec, R C PierceNeuroscience|July 1, 1995
Iontophoresis in the neostriatum of awake, unrestrained rats: differential effects of dopamine, glutamate and ascorbate on motor- and nonmotor-related neuronsR C Pierce, G V RebecBrain Research|May 1, 1992
Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving ratsR C Pierce, G V RebecNeuropharmacology|February 1, 1991
Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in ratsJ K Rowlett, B A Mattingly, M T BardoSynapse (New York, N.Y.)|July 1, 1995
Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonistsJ K Rowlett, B A Mattingly, M T BardoPageof 30